Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 187

1.

MDM2 and CDK4 immunohistochemical coexpression in high-grade osteosarcoma: correlation with a dedifferentiated subtype.

Yoshida A, Ushiku T, Motoi T, Beppu Y, Fukayama M, Tsuda H, Shibata T.

Am J Surg Pathol. 2012 Mar;36(3):423-31. doi: 10.1097/PAS.0b013e31824230d0.

PMID:
22301501
2.

MDM2 and CDK4 immunohistochemistry is a valuable tool in the differential diagnosis of low-grade osteosarcomas and other primary fibro-osseous lesions of the bone.

Dujardin F, Binh MB, Bouvier C, Gomez-Brouchet A, Larousserie F, Muret Ad, Louis-Brennetot C, Aurias A, Coindre JM, Guillou L, Pedeutour F, Duval H, Collin C, de Pinieux G.

Mod Pathol. 2011 May;24(5):624-37. doi: 10.1038/modpathol.2010.229. Epub 2011 Feb 18.

3.

Immunohistochemical analysis of MDM2 and CDK4 distinguishes low-grade osteosarcoma from benign mimics.

Yoshida A, Ushiku T, Motoi T, Shibata T, Beppu Y, Fukayama M, Tsuda H.

Mod Pathol. 2010 Sep;23(9):1279-88. doi: 10.1038/modpathol.2010.124. Epub 2010 Jul 2.

4.

Clinical outcome of low-grade central osteosarcoma and role of CDK4 and MDM2 immunohistochemistry as a diagnostic adjunct.

Jeon DG, Koh JS, Cho WH, Song WS, Kong CB, Cho SH, Lee SY, Lee SY.

J Orthop Sci. 2015 May;20(3):529-37. doi: 10.1007/s00776-015-0701-0. Epub 2015 Mar 5.

PMID:
25740728
5.

MDM2 and CDK4 expression in periosteal osteosarcoma.

Righi A, Gambarotti M, Benini S, Gamberi G, Cocchi S, Picci P, Bertoni F.

Hum Pathol. 2015 Apr;46(4):549-53. doi: 10.1016/j.humpath.2014.12.006. Epub 2014 Dec 31.

PMID:
25680902
6.

A new subtype of high-grade mandibular osteosarcoma with RASAL1/MDM2 amplification.

Guérin M, Thariat J, Ouali M, Bouvier C, Decouvelaere AV, Cassagnau E, Aubert S, Lepreux S, Coindre JM, Valmary-Degano S, Larousserie F, Meilleroux J, Projetti F, Stock N, Galant C, Marie B, Peyrottes I, de Pinieux G, Gomez-Brouchet A.

Hum Pathol. 2016 Apr;50:70-8. doi: 10.1016/j.humpath.2015.11.012. Epub 2015 Dec 9.

PMID:
26997440
7.

Retroperitoneal dedifferentiated liposarcoma with osteosarcomatous components: a case report.

Fujii T, Arai T, Sakon M, Sawano S, Momose Y, Ishii K, Miwa S.

Int J Clin Exp Pathol. 2013 Jun 15;6(7):1427-31. Print 2013.

8.

Amplification and protein expression of chromosome 12q13-15 genes in osteosarcomas of the jaws.

Lopes MA, Nikitakis NG, Ord RA, Sauk J Jr.

Oral Oncol. 2001 Oct;37(7):566-71.

PMID:
11564577
9.

Well-differentiated liposarcoma with low-grade osteosarcomatous component: an underrecognized variant.

Yoshida A, Ushiku T, Motoi T, Shibata T, Fukayama M, Tsuda H.

Am J Surg Pathol. 2010 Sep;34(9):1361-6. doi: 10.1097/PAS.0b013e3181ebcc45.

PMID:
20697254
10.

Dedifferentiated liposarcoma with "homologous" lipoblastic (pleomorphic liposarcoma-like) differentiation: clinicopathologic and molecular analysis of a series suggesting revised diagnostic criteria.

Mariño-Enríquez A, Fletcher CD, Dal Cin P, Hornick JL.

Am J Surg Pathol. 2010 Aug;34(8):1122-31. doi: 10.1097/PAS.0b013e3181e5dc49.

PMID:
20588177
11.

Characterization of the 12q15 MDM2 and 12q13-14 CDK4 amplicons and clinical correlations in osteosarcoma.

Mejia-Guerrero S, Quejada M, Gokgoz N, Gill M, Parkes RK, Wunder JS, Andrulis IL.

Genes Chromosomes Cancer. 2010 Jun;49(6):518-25. doi: 10.1002/gcc.20761.

PMID:
20196171
12.

Diagnostic utility of p16, CDK4, and MDM2 as an immunohistochemical panel in distinguishing well-differentiated and dedifferentiated liposarcomas from other adipocytic tumors.

Thway K, Flora R, Shah C, Olmos D, Fisher C.

Am J Surg Pathol. 2012 Mar;36(3):462-9. doi: 10.1097/PAS.0b013e3182417330.

PMID:
22301498
13.

[Value of MDM2, CDK4 and SATB2 immunohistochemistry in histologic diagnosis of low-grade osteosarcoma].

Chen CY, Zhang HZ, Jiang ZM, Zhou J, Chen J, Liu L.

Zhonghua Bing Li Xue Za Zhi. 2016 Jun 8;45(6):387-92. doi: 10.3760/cma.j.issn.0529-5807.2016.06.007. Chinese.

PMID:
27256046
14.

Molecular analysis of p53, MDM2 and H-ras genes in low-grade central osteosarcoma.

Park HR, Jung WW, Bertoni F, Bacchini P, Park JH, Kim YW, Park YK.

Pathol Res Pract. 2004;200(6):439-45.

PMID:
15310147
15.

Analysis of 12q13-15 genes in parosteal osteosarcoma.

Gamberi G, Ragazzini P, Benassi MS, Ferrari C, Sollazzo MR, Molendini L, Merli M, Magagnoli G, Ruggieri P, Balladelli A, Orlando C, Bacchini P, Pazzagli M, Picci P.

Clin Orthop Relat Res. 2000 Aug;(377):195-204.

PMID:
10943202
16.
17.

12q amplification defines a subtype of extraskeletal osteosarcoma with good prognosis that is the soft tissue homologue of parosteal osteosarcoma.

Kyriazoglou AI, Vieira J, Dimitriadis E, Arnogiannaki N, Teixeira MR, Pandis N.

Cancer Genet. 2012 Jun;205(6):332-6. doi: 10.1016/j.cancergen.2012.04.011.

PMID:
22749040
18.

Dedifferentiated liposarcoma and pleomorphic liposarcoma: a comparative study of cytomorphology and MDM2/CDK4 expression on fine-needle aspiration.

Mariño-Enríquez A, Hornick JL, Dal Cin P, Cibas ES, Qian X.

Cancer Cytopathol. 2014 Feb;122(2):128-37. doi: 10.1002/cncy.21362. Epub 2013 Nov 12.

19.

Immunohistochemical and FISH analysis of MDM2 and CDK4 in a dedifferentiated extraskeletal osteosarcoma arising in the vastus lateralis muscle: differential diagnosis and diagnostic algorithm.

von Baer A, Ehrhardt A, Baumhoer D, Mayer-Steinacker R, Schultheiss M, Abdul-Nou T, Mentzel T, Fend F, Möller P, Jundt G, Barth TF.

Pathol Res Pract. 2014 Oct;210(10):698-703. doi: 10.1016/j.prp.2014.05.010. Epub 2014 May 22.

PMID:
24974983
20.

Clinical and biological significance of CDK4 amplification in well-differentiated and dedifferentiated liposarcomas.

Italiano A, Bianchini L, Gjernes E, Keslair F, Ranchere-Vince D, Dumollard JM, Haudebourg J, Leroux A, Mainguené C, Terrier P, Chibon F, Coindre JM, Pedeutour F.

Clin Cancer Res. 2009 Sep 15;15(18):5696-703. doi: 10.1158/1078-0432.CCR-08-3185. Epub 2009 Sep 8.

Supplemental Content

Support Center